The Nutritionals segment will comprise about 25% of sales at the new (i.e. post-ABBV spinoff) ABT. It is ABT’s fastest-growing segment, especially in emerging markets.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”